⚕️ Researchers presented an AI-ECG system that analyses routine heart-tracing tests in under two seconds to flag signs of heart failure and valve disease.
The 67,000-patient US trial found the tool identified up to 81% of heart-failure cases and up to 90% of valve-disease cases. The system was presented at the European Society of Cardiology congress in Munich.
An ECG records electrical activity, while an echocardiogram uses ultrasound to show heart structure, pumping and valves. The proposed use is to prioritise people for follow-up scans, not to make a stand-alone diagnosis. 🫀
That distinction matters because positive screens still need clinical assessment and confirmation. The American Heart Association says cardiovascular AI needs robust prospective validation, while the FDA notes that triage tools and diagnostic tools have different evaluation requirements.